Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Straube

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Trauma|February 1, 1979
White blood cell consumption in the microcirculation after a major burnE Eriksson, R C Straube, M C Robson
Infectious Disease Clinics of North America|March 1, 1992
HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsisC R Smith, R C Straube, E J Ziegler
Critical Care Medicine|September 29, 2000
Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndromeJ L Zimmerman, R P Dellinger, R C Straube, et al.
British Medical Journal (Clinical Research Ed.)|June 15, 1985
Illness associated with contamination of drinking water supplies with phenolS N Jarvis, R C Straube, A L Williams, et al.
Annals of Internal Medicine|July 1, 1994
Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study GroupR V McCloskey, R C Straube, C Sanders, et al.
The Journal of Infectious Diseases|May 1, 1983
Adenovirus type 7b in a children's hospitalR C Straube, M A Thompson, R B Van Dyke, et al.
Critical Care Medicine|March 1, 1997
Influence of alterations in foregoing life-sustaining treatment practices on a clinical sepsis trial. The HA-1A Sepsis Study GroupC L Sprung, L A Eidelman, R Pizov, et al.
Critical Care Medicine|January 15, 1998
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study GroupR P Dellinger, J L Zimmerman, R W Taylor, et al.
Journal of Clinical Microbiology|April 1, 1987
Peroxidase-antiperoxidase assay for rapid detection of respiratory syncytial virus in nasal epithelial specimens from infants and childrenA A Jalowayski, B L England, C J Temm, et al.
The Journal of Pediatrics|June 1, 1993
Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndromeM J Romano, G L Kearns, S L Kaplan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Trauma|February 1, 1979
White blood cell consumption in the microcirculation after a major burnE Eriksson, R C Straube, M C Robson
Infectious Disease Clinics of North America|March 1, 1992
HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsisC R Smith, R C Straube, E J Ziegler
Critical Care Medicine|September 29, 2000
Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndromeJ L Zimmerman, R P Dellinger, R C Straube, et al.
British Medical Journal (Clinical Research Ed.)|June 15, 1985
Illness associated with contamination of drinking water supplies with phenolS N Jarvis, R C Straube, A L Williams, et al.
Annals of Internal Medicine|July 1, 1994
Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study GroupR V McCloskey, R C Straube, C Sanders, et al.
The Journal of Infectious Diseases|May 1, 1983
Adenovirus type 7b in a children's hospitalR C Straube, M A Thompson, R B Van Dyke, et al.
Critical Care Medicine|March 1, 1997
Influence of alterations in foregoing life-sustaining treatment practices on a clinical sepsis trial. The HA-1A Sepsis Study GroupC L Sprung, L A Eidelman, R Pizov, et al.
Critical Care Medicine|January 15, 1998
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study GroupR P Dellinger, J L Zimmerman, R W Taylor, et al.
Journal of Clinical Microbiology|April 1, 1987
Peroxidase-antiperoxidase assay for rapid detection of respiratory syncytial virus in nasal epithelial specimens from infants and childrenA A Jalowayski, B L England, C J Temm, et al.
The Journal of Pediatrics|June 1, 1993
Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndromeM J Romano, G L Kearns, S L Kaplan, et al.
Pageof 2